SEC Comment Letter 0000000000-24-002347 to CHIMERIX INC (CIK 0001117480)
CHIMERIX INC (CIK 0001117480)
Date: March 1, 2024 · CIK: 0001117480 · Accession: 0000000000-24-002347
AI Filing Summary & Sentiment
File numbers found in text: 333-277505
Letter
United States securities and exchange commission logo March 1, 2024 Michael T. Andriole President and Chief Executive Officer Chimerix, Inc. 2505 Meridian Parkway, Suite 100 Durham, NC 27713 Re:Chimerix, Inc. Registration Statement on Form S-3 Filed February 29, 2024 File No. 333-277505 Dear Michael T. Andriole: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jason L. Kent, Esq.
Show Raw Text
United States securities and exchange commission logo
March 1, 2024
Michael T. Andriole
President and Chief Executive Officer
Chimerix, Inc.
2505 Meridian Parkway, Suite 100
Durham, NC 27713
Re:Chimerix, Inc.
Registration Statement on Form S-3
Filed February 29, 2024
File No. 333-277505
Dear Michael T. Andriole:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Jason L. Kent, Esq.